BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24134932)

  • 1. 9p21 gene locus in Spitz nevi of older individuals: absence of cytogenetic and immunohistochemical findings associated with malignancy.
    Horst BA; Terrano D; Fang Y; Silvers DN; Busam KJ
    Hum Pathol; 2013 Dec; 44(12):2822-8. PubMed ID: 24134932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Diagnostic Algorithm Combining Immunohistochemistry and Molecular Cytogenetics to Diagnose Challenging Melanocytic Tumors.
    Redon S; Guibourg B; Talagas M; Marcorelles P; Uguen A
    Appl Immunohistochem Mol Morphol; 2018; 26(10):714-720. PubMed ID: 28362709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
    Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
    J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Amount of Melanin Influences p16 Loss in Spitzoid Melanocytic Lesions: Correlation With CDKN2A Status by FISH and MLPA.
    Martinez Ciarpaglini C; Gonzalez J; Sanchez B; Agusti J; Navarro L; Nieto G; Monteagudo C
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):423-429. PubMed ID: 29489509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of p16-Ki-67-HMB45 score in sorting benign from malignant Spitz tumors.
    Garola R; Singh V
    Pathol Res Pract; 2019 Oct; 215(10):152550. PubMed ID: 31351802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence in situ hybridization for the differential diagnosis between Spitz naevus and spitzoid melanoma.
    Requena C; Rubio L; Traves V; Sanmartín O; Nagore E; Llombart B; Serra C; Fernández-Serra A; Botella R; Guillén C
    Histopathology; 2012 Nov; 61(5):899-909. PubMed ID: 22882594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.
    Gammon B; Beilfuss B; Guitart J; Gerami P
    Am J Surg Pathol; 2012 Jan; 36(1):81-8. PubMed ID: 21989344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined utility of p16 and BRAF V600E in the evaluation of spitzoid tumors: Superiority to PRAME and correlation with FISH.
    McAfee JL; Scarborough R; Jia XS; Azzato EM; Astbury C; Ronen S; Andea AA; Billings SD; Ko JS
    J Cutan Pathol; 2023 Feb; 50(2):155-168. PubMed ID: 36261329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
    Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
    Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.
    Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY
    J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reevaluation of established and new criteria in differential diagnosis of Spitz nevus and melanoma.
    Ritter A; Tronnier M; Vaske B; Mitteldorf C
    Arch Dermatol Res; 2018 May; 310(4):329-342. PubMed ID: 29417221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical Spitz Tumors: A Diagnostic Challenge.
    Harms KL; Lowe L; Fullen DR; Harms PW
    Arch Pathol Lab Med; 2015 Oct; 139(10):1263-70. PubMed ID: 26414472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal aberrations by 4-color fluorescence in situ hybridization not detected in Spitz nevi of older individuals.
    Horst BA; Fang Y; Silvers DN; Busam KJ
    Arch Dermatol; 2012 Oct; 148(10):1152-6. PubMed ID: 23069951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical evaluation of p16INK4A, E-cadherin, and cyclin D1 expression in melanoma and Spitz tumors.
    George E; Polissar NL; Wick M
    Am J Clin Pathol; 2010 Mar; 133(3):370-9. PubMed ID: 20154275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
    van Dijk MC; Bernsen MR; Ruiter DJ
    Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spitzoid tumors in children and adults: a comparative clinical, pathological, and cytogenetic analysis.
    Dika E; Fanti PA; Fiorentino M; Capizzi E; Neri I; Piraccini BM; Ravaioli GM; Misciali C; Passarini B; Patrizi A
    Melanoma Res; 2015 Aug; 25(4):295-301. PubMed ID: 25933206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis.
    Martin V; Banfi S; Bordoni A; Leoni-Parvex S; Mazzucchelli L
    Histopathology; 2012 Jan; 60(2):336-46. PubMed ID: 22211292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.